MiR-99a targets CTDSPL and TRIB2, and regulates their expressions in most childhood AML and CML, which may reveal a new post-transcriptional mechanism of regulation in the myeloid lineage. The gene discussed is CTDSPL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.